Eagle Health Investments
Latest statistics and disclosures from Eagle Health Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ARGX, ICLR, GH, INSM, BMRN, and represent 40.81% of Eagle Health Investments's stock portfolio.
- Added to shares of these 10 stocks: ASND (+$28M), INSM (+$17M), AXSM (+$16M), IONS (+$15M), DNTH (+$13M), PTGX (+$8.5M), BMRN (+$6.8M), AVTX, SRRK, BSX.
- Started 6 new stock positions in IONS, LLY, ASND, AXSM, AVTX, DNTH.
- Reduced shares in these 10 stocks: , NTRA (-$29M), TERN (-$22M), BBIO (-$20M), Ascendis Pharma A S (-$20M), PRCT (-$14M), ICLR (-$8.7M), Centessa Pharmaceuticals (-$8.5M), FTRE, GH.
- Sold out of its positions in Ascendis Pharma A S, BBIO, Centessa Pharmaceuticals, PRCT, XBI, TERN.
- Eagle Health Investments was a net seller of stock by $-95M.
- Eagle Health Investments has $603M in assets under management (AUM), dropping by 5.51%.
- Central Index Key (CIK): 0001842545
Tip: Access up to 7 years of quarterly data
Positions held by Eagle Health Investments consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Eagle Health Investments
Eagle Health Investments holds 27 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 11.8 | $71M | 76k | 927.77 |
|
|
| Icon Pub SHS (ICLR) | 8.9 | $54M | -14% | 308k | 173.71 |
|
| Guardant Health (GH) | 7.5 | $45M | -3% | 301k | 150.03 |
|
| Insmed Com Par $.01 (INSM) | 6.8 | $41M | +71% | 384k | 106.62 |
|
| BioMarin Pharmaceutical (BMRN) | 5.9 | $36M | +23% | 625k | 57.22 |
|
| Illumina (ILMN) | 5.5 | $33M | 187k | 175.83 |
|
|
| Scholar Rock Hldg Corp (SRRK) | 5.1 | $31M | +12% | 555k | 55.00 |
|
| Protagonist Therapeutics (PTGX) | 5.0 | $30M | +38% | 248k | 122.58 |
|
| Ultragenyx Pharmaceutical (RARE) | 4.9 | $30M | 884k | 33.39 |
|
|
| Compass Pathways Sponsored Ads (CMPS) | 4.8 | $29M | 2.1M | 14.15 |
|
|
| Ascendis Pharma A/s Ord Shs (ASND) | 4.7 | $28M | NEW | 106k | 266.72 |
|
| Revolution Medicines (RVMD) | 3.7 | $23M | 120k | 187.28 |
|
|
| Fortrea Hldgs Common Stock (FTRE) | 3.4 | $21M | -9% | 1.2M | 17.40 |
|
| Kymera Therapeutics (KYMR) | 3.2 | $19M | +13% | 166k | 114.67 |
|
| Axsome Therapeutics (AXSM) | 2.6 | $16M | NEW | 65k | 244.77 |
|
| Boston Scientific Corporation (BSX) | 2.6 | $16M | +25% | 369k | 42.68 |
|
| Alkermes SHS (ALKS) | 2.6 | $16M | +24% | 297k | 52.40 |
|
| Ionis Pharmaceuticals (IONS) | 2.6 | $15M | NEW | 195k | 79.29 |
|
| Tempus Ai Cl A (TEM) | 2.5 | $15M | 256k | 57.93 |
|
|
| Dianthus Therapeutics (DNTH) | 2.1 | $13M | NEW | 131k | 97.48 |
|
| Ataibeckley Com Shs (ATAI) | 1.5 | $9.0M | 1.7M | 5.27 |
|
|
| Avalo Therapeutics Com New (AVTX) | 0.7 | $4.3M | NEW | 235k | 18.48 |
|
| Natera (NTRA) | 0.7 | $4.3M | -86% | 16k | 271.45 |
|
| Eli Lilly & Co. (LLY) | 0.4 | $2.4M | NEW | 2.0k | 1199.43 |
|
| Intuitive Surgical Com New (ISRG) | 0.3 | $1.7M | 4.4k | 397.68 |
|
|
| Immunocore Hldgs Ads (IMCR) | 0.2 | $1.5M | 46k | 31.75 |
|
|
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.1 | $410k | 38k | 10.88 |
|
Past Filings by Eagle Health Investments
SEC 13F filings are viewable for Eagle Health Investments going back to 2020
- Eagle Health Investments 2026 Q2 filed Aug. 10, 2026
- Eagle Health Investments 2026 Q1 filed May 15, 2026
- Eagle Health Investments 2025 Q4 filed Feb. 6, 2026
- Eagle Health Investments 2025 Q3 filed Nov. 7, 2025
- Eagle Health Investments 2025 Q2 filed Aug. 12, 2025
- Eagle Health Investments 2025 Q1 filed May 12, 2025
- Eagle Health Investments 2024 Q4 filed Feb. 12, 2025
- Eagle Health Investments 2024 Q3 filed Nov. 12, 2024
- Eagle Health Investments 2024 Q1 filed May 14, 2024
- Eagle Health Investments 2023 Q4 filed Feb. 12, 2024
- Eagle Health Investments 2023 Q3 filed Oct. 27, 2023
- Eagle Health Investments 2023 Q2 filed Aug. 14, 2023
- Eagle Health Investments 2023 Q1 filed May 12, 2023
- Eagle Health Investments 2022 Q4 filed Feb. 13, 2023
- Eagle Health Investments 2022 Q3 filed Nov. 14, 2022
- Eagle Health Investments 2022 Q2 filed Aug. 11, 2022